Non-selective melanocortin action
Also known as: MT-2 · MT-II · MT-2 Melanotan 2 Acetate · Melanotin Receptor Type 2 · Synthetic melanocortin peptide
The essentials at a glance
Influences pigmentation and other melanocortin signals; safety and purity of unapproved products are uncertain.
Distinction: Melanotan II is a non-selective, unapproved precursor from which the approved agents afamelanotide and bremelanotide were developed.
Claims rely mostly on personal experience reports and vendor statements rather than controlled studies.
Not FDA/EMA approved: No FDA- or EMA-approved medicinal product; efficacy and safety are not established.
Research questions
This studies how a substance engages several melanocortin receptor subtypes at once rather than just one, potentially causing broader but less predictable effects, comparable to a master key rather than a single key. Various body responses are measured in parallel in studies.
This studies how activating melanocortin receptors affects pigmentation or sexual arousal signals, like a switch controlling different body functions depending on the receptor subtype. Skin pigmentation or physiological arousal markers are measured in studies.
This studies how skin pigment cells respond to signals that darken skin, potentially reducing sensitivity to sunlight, similar to how a photograph darkens with more exposure. Researchers typically measure skin pigment levels and light sensitivity in study participants.
Simple example
Think of it like a component still being tested in a development workshop, not yet cleared for general use.
Research status means efficacy, dosing, and safety in humans are not yet conclusively established.
Community themes
Personal experience reports and vendor marketing from communities are not scientific proof of efficacy.
Users compare tanning or skin changes after using melanocortin-related substances, often based on shared photos rather than medical examination. Such posts do not establish reviewed safety, especially for unapproved variants.
Discussion covers which vendors are seen as more trustworthy and how purity test results differ between batches. Such community assessments are based on limited samples and do not replace independent lab testing of each individual batch.
Vendors often advertise products with broad efficacy claims, comparison tables against competitors, and customer quotes. Such marketing statements are driven by sales interest and do not constitute independent scientific proof of efficacy.
Why individual profiles do not contain mixing instructions
Reconstitution depends on the exact product, label, identity, concentration, sterility and stability. Arithmetic examples appear only in the separately labelled community area and are not recommendations.
Reconstitution & quantitiesOpen basics, units and sourcesUse & mixingEvidence boundary
Safety and purity of unapproved products are uncertain, and robust human data are lacking.
No peptide sales or individual recommendations. A separately labelled community area documents third-party protocol claims without medically endorsing them.
Primary sources
Regulators, trial registries and scientific databases support the classification and carry more weight than vendor or community claims.
